Cole FM, Laszlo GS, Lunn-Halbert MC, Kehret AR, et al. Preclinical characterization of the anti-leukemia activity of the CD123 antibody-drug conjugate, pivekimab sunirine (IMGN632). Leukemia 2025 Mar 21. doi: 10.1038/s41375-025-02571.
PMID: 40119158